Literature DB >> 1170715

Actions of dopaminergic agonists on motor function.

B Costall, R J Naylor.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1170715

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  10 in total

1.  Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.

Authors:  B Costall; C D Marsden; R J Naylor; C J Pycock
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Methylphenidate attenuates rats' preference for a novel spatial stimulus introduced into a familiar environment: assessment using a force-plate actometer.

Authors:  Stephen C Fowler; Troy J Zarcone; Beth Levant
Journal:  J Neurosci Methods       Date:  2010-03-25       Impact factor: 2.390

3.  Differences in methylphenidate dose response between periadolescent and adult rats in the familiar arena-novel alcove task.

Authors:  Beth Levant; Troy J Zarcone; Paul F Davis; Marlies K Ozias; Stephen C Fowler
Journal:  J Pharmacol Exp Ther       Date:  2010-12-28       Impact factor: 4.030

4.  L-Dopa and piribedil alter different components of attentional behavior dependent on dose.

Authors:  M Cheal
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  A comparative review of the pharmacology of nomifensine.

Authors:  I Hoffmann
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

Review 6.  Parkinson's disease: pathological mechanisms and actions of piribedil.

Authors:  P Jenner
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

7.  Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism.

Authors:  Erika N Allen; Sneha Potdar; Victor Tapias; Mayur Parmar; Cassia S Mizuno; Agnes Rimando; Jane E Cavanaugh
Journal:  J Nutr Biochem       Date:  2017-11-04       Impact factor: 6.048

8.  Differential effects of haloperidol and clozapine on attention.

Authors:  M Cheal
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Nomifensine in parkinsonism.

Authors:  P F Teychenne; D M Park; L J Findley; F C Rose; D B Calne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

10.  Controlled randomized group comparison of nomifensine and imipramine in depressive illness.

Authors:  A Forrest; A Hewett; P Nicholson
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.